Atrial Fibrillation Market

Atrial Fibrillation (AF) is the most common cardiac arrhythmia and is characterized by a rapid and uncontrolled beating of the upper chambers of the heart.  AF affects approximately 3 million patients in the US, and over 6.7 million in the US and Europe combined.  AF is a leading cause of stroke in patients 65 years and older.  Each year there are between 200,000 and 400,000 new AF cases diagnosed in the U.S., and the rate of incidence is increasing.  Researchers have estimated that AF prevalence in the US will exceed 10 million patients by 2050.